Trending
July 9, 2024

Annovis Bio Welcomes Four New Executives

July 9, 2024

VYNE Therapeutics Appoints Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development

July 9, 2024

Moderna Founder’s Apriori Bio Gets $1.1M from Gates Foundation-funded CEPI

July 8, 2024

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing

July 8, 2024

Fairmount Partners Advises Think Research on Sale of BioPharma Services to HEALWELL AI

July 8, 2024

TEDCO-backed Biotech Firm Phycin Raises $200K to Advance Algae Development

July 3, 2024

Quest Diagnostics to Acquire LifeLabs from OMERS

July 2, 2024

Independence Blue Cross Promotes Mike Lentz and Tracy Mueller to Vice Presidents

July 2, 2024

Tobin Scientific Acquires BioRepository Resources

July 2, 2024

CytoSorbents Secures $20 Million Credit Facility

July 1, 2024

Carisma Therapeutics Appoints Marella Thorell and David Scadden, M.D., to Board

July 1, 2024

NRx Pharmaceuticals Publishes Shareholder Update Letter

July 1, 2024

Kanvas Biosciences Secures Additional $12.5M Funding

June 28, 2024

NRx Pharmaceuticals to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing

June 28, 2024

Savara Prices of $100.0 Million Underwritten Offering of Common Stock

June 27, 2024

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes